{"id":5840,"date":"2025-03-20T14:41:57","date_gmt":"2025-03-20T21:41:57","guid":{"rendered":"https:\/\/www.iths.org\/participate\/?p=5840"},"modified":"2025-03-20T14:41:57","modified_gmt":"2025-03-20T21:41:57","slug":"cerus-intercept-radiolabeled-platelet-study-2","status":"publish","type":"post","link":"https:\/\/www.iths.org\/participate\/cerus-intercept-radiolabeled-platelet-study-2\/","title":{"rendered":"Cerus INTERCEPT Radiolabeled Platelet Study"},"content":{"rendered":"
<\/div>\n

This is a platelet transfusion study. The primary purpose of this study is to find out how long platelets treated with the INTERCEPT blood system and stored for up to 5 days remain in your blood after transfusion. The INTERCEPT blood system for platelets is a treatment performed on a unit of platelets to reduce the risk of diseases transmitted by blood transfusions. This study involves using a radioactive material added to your platelets to track platelets in your blood. Your platelets will be collected using an apheresis procedure. Your platelets will be stored for 5 days. A radioactive material will be added to a small amount of your stored platelets. Your radiolabeled platelets will be given back to you and follow-up blood draws will be done to see how many of your platelets are circulating.<\/p>\n

There will be a total of 9 visits over 34 days. Each study visit lasts from 30 minutes to 3 hours. Study visits will occur at Bloodworks Northwest- 1551 Eastlake Ave. East, Suite 100, Seattle, WA 98102. Participants will be compensated up to $1200.00 for time involved in the study.<\/p>\n

Participant Eligibility<\/h3>\n

Inclusion Criteria:
\n\u2022 At least 18 years of age.
\n\u2022 Be in good health.
\n\u2022 Weigh at least 114 lbs.
\n\u2022 Meet study criteria for an apheresis platelet collection.
\n\u2022 Not be taking medication known to interfere with platelet function such as aspirin, nonsteroidal anti-inflammatory drugs such as ibuprofen (Advil, Motrin) or naproxen (Aleve), or platelet inhibitors given for heart disease.
\n\u2022 Test negative for infectious diseases as part of blood donor screening.
\nExclusion Criteria:
\n\u2022 Acute or chronic health conditions that may affect study results.
\n\u2022 Pregnant or nursing females.
\n\u2022 Test positive for cocaine or amphetamine use by urine drug screen test.
\n\u2022 Not have a spleen.
\n\u2022 History of known hypersensitivity to indium or chromium.
\n\u2022 On other investigation drug studies within the past 28 days.<\/p>\n

Contact<\/h3>\n

Patricia Klotz
\n(206) 568-2238<\/p>\n

<\/p>\n

Additional Study Details<\/h3>\n

Full Study Title<\/strong>
\nA Randomized, Multi-center, Controlled, In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous Apheresis Platelet Components Suspended in 100% Plasma Treated with the INTERCEPT Blood System for Platelets with LED Illuminator Stored for 5 Days
\n<\/span><\/p>\n

Study ID:<\/strong> 20250668<\/div>\n
ClinicalTrials.gov Link:<\/strong> NCT06697223<\/a><\/div>\n
<\/div>\n
Start Date:<\/strong> 03\/18\/2025<\/div>\n
End Date:<\/strong> 11\/04\/2025<\/div>\n
<\/div>\n

Investigator(s)<\/strong>
\nDr. Moritz Stolla
\n<\/span>
\nAccepts Healthy Volunteers?<\/strong>
\nYes<\/span><\/p>\n

Study Site(s)<\/strong><\/p>\n

\n

Bloodworks NW Research Institute<\/h4>\n

1551 Eastlake Ave E, Suite 100
\nSeattle, Washington 98102<\/p>\n<\/div>\n

\n

<\/h4>\n<\/div>\n
<\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

This is a platelet transfusion study. The primary purpose of this study is to find out how long platelets treated with the INTERCEPT blood system and stored for up to 5 days remain in your blood after transfusion. The INTERCEPT blood system for platelets is…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[98],"class_list":["post-5840","post","type-post","status-publish","format-standard","hentry","category-blood-lymphatic-system","tag-healthy-volunteers"],"_links":{"self":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts\/5840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/comments?post=5840"}],"version-history":[{"count":3,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts\/5840\/revisions"}],"predecessor-version":[{"id":5843,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts\/5840\/revisions\/5843"}],"wp:attachment":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/media?parent=5840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/categories?post=5840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/tags?post=5840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}